Navigation Links
ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
Date:4/23/2009

, its effectiveness at managing its financial resources, its ability to enter into transactions around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its product candidates, regulatory developments involving its product candidates and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2008. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
2. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
3. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
6. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
9. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
10. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
11. Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... second quarter 2014 financial results for the period ended June ... PDL,s management will host a conference call and webcast that ... results.  A slide presentation relating to the call will be ... Conference Call Details To access the live conference ...
(Date:7/28/2014)...  ProteinSimple announced today that it has launched a ... allows users to detect all proteins separated in the ... can analyze proteins without the need for an antibody.  ... analysis as we know it today. First, the Simple Western ... messy gels, no transfer tanks, no blots, no imaging ...
(Date:7/28/2014)... Germany and LONDON ... , Collaboration aims to create and commercialize ... guide the use of IRESSA  for non-small cell lung ... on QIAGEN,s FDA-approved  therascreen   EGFR test and is planned ... automated instruments  Project enabled by AstraZeneca master ...
Breaking Medicine Technology:PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
... - GenoMed (OTC Pink,Sheets:GMED), the Next Generation Disease ... publication of a,case report of a sickle cell ... thanks to GenoMed's treatment., The patient is a ... pain pills every day to tolerate the pain,of ...
... Industries Limited,(ASX: PGL; NASDAQ: PGLA) is pleased to announce ... accepted for late breaking news,presentation by the European Association ... be presenting the results of this liver,cancer trial at ... , ,In expectation of having final data fully ...
Cached Medicine Technology:GenoMed Prevents Sickle Cell Pain for Over a Year 2PI-88 Data to be Presented at Key International Conferences 2PI-88 Data to be Presented at Key International Conferences 3
(Date:7/28/2014)... at North Carolina State University is proposing a new ... ability with age, but don,t necessarily show declines in ... be how motivated older adults are to maintain focus ... wanted to explain the difference we see in cognitive ... professor of psychology at NC State and author of ...
(Date:7/28/2014)... July 28, 2014 Top Northridge dentist ... for new patients. Finding a new dentist can be an ... issues that have gone untreated and worry about how they ... specializes in patients with special concerns and dental needs and ... and right at home. This special coupon can help patients ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Freeonlinelifeinsuranceleads.com has ... advantages of comparing online life insurance quotes. , Comparing ... 40% of their life insurance costs. Finding affordable coverage ... websites gather quotes from reliable agencies and displays them ... life insurance quotes, clients can find cheaper coverage, but ...
(Date:7/28/2014)... a healthy lifestyle may help childhood cancer survivors reduce ... indicates. Researchers suggested that children with cancer and ... about how their diet and certain behaviors could ... are important because they indicate that adults who were ... influence their own health outcomes," said one of the ...
(Date:7/28/2014)... 2014 Mahendra Trivedi, accompanied by Trivedi ... Online Workshop ‘Consciousness is Power’ on July 26, 2014 ... workshop, participants from all over the world received profound ... deeper connection to their inner guidance system. , On ... various advantages of raising consciousness and thus, enjoying the ...
Breaking Medicine News(10 mins):Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:Comparing Life Insurance Quotes Online Offers 3 Important Advantages! 2Health News:Healthy Habits May Help Childhood Cancer Survivors Avoid Chronic Ills 2Health News:Trivedi Online Workshop ‘Consciousness is Power’ was Huge Success 2Health News:Trivedi Online Workshop ‘Consciousness is Power’ was Huge Success 3
... THURSDAY, March 5 (HealthDay News) -- If you,re over 50, ... third glass of wine as well as you used to, ... adults who are social drinkers can become impaired by alcohol ... University of Kentucky researchers report. , Most studies on ...
... 2009) -- Two highly lethal viruses that have emerged in ... to prevent and treat malaria, according to a new basic ... the Journal of Virology . Due to the study,s ... print issue, and will be highlighted as an,editor,s "spotlight" in ...
... information about potential risk from exposure to medications, chemicals ... about potential risks of taking cold medication or using ... and over the phone. A new Web ... source for finding the latest information about the potential ...
... broccoli, cabbage block protein in disease spread, study says ... based on compounds extracted from cruciferous vegetables such as ... treatment against melanoma, Penn State College of Medicine researchers ... compounds (called isothiocyanates) and selenium slowed production and blocked ...
... Supreme Court ruling against preemption is disastrous for patient ... and clearly elevates trial lawyers and local juries as ... court has decided that federal law does not preempt ... a flood of frivolous liability lawsuits will cause patients ...
... failure, stroke and heart disease are potential complications of ... million Americans. Now research from Tel Aviv University has ... be a risk factor accelerating cognitive decline and dementia. ... from TAU,s Sackler School of Medicine, found that people ...
Cached Medicine News:Health News:Older Adults Get Drunk Faster Than Younger Drinkers 2Health News:Older Adults Get Drunk Faster Than Younger Drinkers 3Health News:Drug blocks two of world's deadliest emerging viruses 2Health News:Drug blocks two of world's deadliest emerging viruses 3Health News:New Online Service Helps Expectant Moms 2Health News:Drugs From Vegetables May Target Melanoma Tumors 2Health News:High Court Ruling Against Preemption Hurts Patients, Helps Trial Lawyers 2Health News:New Tel Aviv University research links diabetes to cognitive deterioration 2
Endotracheal Tube Stylet- Adult, Copper, Malleable, Non-Sterile, Latex Free, Suitable for tubes 5.0 mm I.D. or larger....
... manipulation. Prevent dental and soft tissue damage. ... to X-ray. Light-guided intubation is based upon ... the neck. This technique takes advantage of ... to the esophagus. A well-defined, circumscribed glow ...
Bivona® stylets are manufactured of malleable stainless steel wire. The length can be adjusted by sliding the attached silicone stopper. The Blue Line® tracheal tube introducer (bougie) is de...
... flexible lighting products. The first is available ... sizes 5", 10", and 15" (refers to ... These lights are for use in procedures ... second group of flexible lights is our ...
Medicine Products: